Crohn's Disease Treatment Market Analysis 2024-2033 : Forecast Market Size, Top Segments And Largest Region | AbbVie Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Celgene Corporation

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Crohn's Disease Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $16.32 billion In 2028 At A CAGR Of 6.7% :

The crohn's disease treatment market size has grown strongly in recent years. It will grow from $11.82 billion in 2023 to $12.6 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increased disease prevalence, advancements in diagnostic techniques, biological therapies adoption, patient awareness and education, clinical research and development..

The crohn's disease treatment market size is expected to see strong growth in the next few years. It will grow to $16.32 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to personalized medicine approaches, biologics market expansion, evolving treatment guidelines, increased healthcare spending, collaborative research efforts.. Major trends in the forecast period include telemedicine for patient management, research on immune modulation strategies, patient-centric care models, integration of digital health solutions..

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=10852&type=smp

Crohn's Disease Treatment Market Major Segments
The crohn's disease treatment market covered in this report is segmented -

1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine Post-Operative Pain, Cancer Pain, Other Applications

Key Driver - Rising Tide Of Inflammatory Bowel Disorders Drives Crohn'S Disease Treatment Market

The increase in the prevalence of inflammatory bowel disorders is expected to propel the growth of the Crohn's disease treatment market going forward. Inflammatory bowel disorders refer to a group of chronic conditions involving gastrointestinal tract inflammation. It can cause inflammation and damage to any part of the digestive system, from the mouth to the anus. Crohn's disease helps by decreasing the inflammation of the intestine, to prevent flare-ups of symptoms, and to keep in remission. For instance, in April 2020, according to a survey by the American Gastroenterological Association covering 33 countries on six continents regarding the prevalence of and factors associated with functional gastrointestinal disorders, among the 73,076 adult respondents, more than 40% of persons worldwide have Functional gastrointestinal disorders (FGIDs), which affect the quality of life and health care use. Therefore, the increase in the prevalence of inflammatory bowel disorders is driving the growth of the Crohn's disease treatment market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=10852&type=smp

Prominent Trend - Product Innovation Propels Crohn's Disease Treatment To New Heights

Product innovation is the key trend gaining popularity in the Crohn's disease treatment market. Major companies operating in the Crohn's disease treatment sector are focused on developing innovative products to strengthen their position in the market. For instance, in May 2023, AbbVie Inc., a US-based pharmaceutical company, received Rinvoq (upadacitinib) approval from U.S. Food and Drug Administration (FDA). Rinvoq is indicated for treating moderate to highly active Crohn's disease. Rinvoq's efficacy and safety were assessed in two randomized induction studies, CD-1 (NCT03345836) and CD-2 (NCT03345849), involving 857 patients with moderately to highly active Crohn's disease.

Crohn's Disease Treatment Market Players
Major companies operating in the crohn's disease treatment market report are AbbVie Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Celgene Corporation, Eli Lilly and Company, Janssen Pharmaceuticals, Pfizer Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Bristol-Myers Squibb Company, Galapagos NV, Gilead Sciences Inc., Novartis AG, Sanofi S.A., Union Chimique Belge, Astellas Pharma Inc., F. Hoffmann-La Roche Ltd., Vertex Pharmaceuticals Incorporated, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Regeneron Pharmaceuticals Inc., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Arena Pharmaceuticals Inc.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the global Crohn's disease treatment market in 2023, and is expected to be the fastest-growing region in the forecast period. The regions covered in the crohn's disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Crohn's Disease Treatment Market Report Structure
3. Crohn's Disease Treatment Market Trends And Strategies
4. Crohn's Disease Treatment Market - Macro Economic Scenario
5. Crohn's Disease Treatment Market Size And Growth
…..
27. Crohn's Disease Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.